Introduction
The concern for sudden unexpected death in epilepsy (SUDEP) and the need for better seizure control in persons with epilepsy (PWE) have led to the implementation of seizure detection devices (SDD). Timely identification of seizures may lead to decreased SUDEP risk [1] and a reduction in the potential for seizure related injury and status epilepticus. Accurate detection of seizures and creation of alarms should improve monitoring of treatment efficacy, as patient reporting is not completely reliable [2] [3] [4] . Different methods for detection of biomarkers are under development [5] [6] [7] [8] [9] [10] . There is no consensus on which system works for which seizure type or patient, and FDA approval is lacking for most.
Understanding user needs and requirements is critical to product development. We performed a survey of PWE and their caregivers to assess their perspectives regarding the features and priorities that should be considered in design of seizure detection devices.
Methods
This is a prospective non-interventional survey study approved by the institutional review board of Mayo Clinic and performed at a level 4 epilepsy center.
Subjects: The study enrolled patients with uncontrolled epilepsy seen at our center. Adult and pediatric patients in the inpatient and outpatient settings participated. The patients were randomly selected. The survey was completed by the patient when capable or by family or caregivers if unable. The complete numbers of patients and families approached was not tabulated.
Survey: The survey asked for current use of any type of SDD and the type of device being used. Additionally, it queried the degree of worry of undetected seizures, the impact of this worry on diurnal functioning, and the level of interest in using a SDD. These questions were answered using Likert scales ranging from 1 to 7, with lower values indicating less worry, less impact in daytime function/sleep, and less interest in using a device. Furthermore, questions regarding acceptable rates of FP and FN alarms, acceptable times until caregivers are alerted, and insurance coverage and cost were asked (Appendix C-Survey).
Statistics: All statistical analyses were done using IBM1 SPSS1 Statistics version 22.
Results
Ninety-two surveys were completed (27 pediatric, 65 adults) 42 by the patient and 50 by a family member or caregiver. Nearly half of subjects (n = 43) had seizures at least weekly [daily or more (n = 23), daily to weekly (n = 20), weekly to monthly (n = 24), every 6 months (n = 15), >every 6 months (n = 10)]. The majority of the patients (n = 85) had epilepsy refractory to 2 or more medications. All survey results summarized in Table 1 (Appendix B- Table 2 , demographic information).
Degree of worry of undetected seizures
Respondents expressed significant degree worry of the possibility of undetected seizures (Fig. 1A) . The reported effect of this worry on the patient or caregiver sleep quality, as well as diurnal functioning, was moderate (Fig. 1B) .
Interest in using a seizure detection device
The majority of respondents manifested high interest in using a SDD. This interest correlated with the degree of worry of undetected seizures (Fig. 1A) . A Spearman's rank correlation was computed and there is moderate correlation between the degree of worry of undetected seizures and the level of interest in using a SDD (r = 0.489, p = <0.001).
Desired time for use of the device
The majority of respondents (65.6%) indicated that the patient would use the device continuously, regardless of whether the patient is accompanied or not. Some indicated that the device would only be used when the patient is alone or sleeping (Fig. 1B) .
Acceptable rate of false positives (specificity) and false negatives (sensitivity)
The majority of respondents (76.1%) reported an expected FP detection rate 25% to be acceptable. Similarly, a majority (85.9%) reported an expected FN detection rate of 25% to be acceptable (Table 1) .
Maximal time to be alerted on cell phone
Most respondents (76.1%) reported an acceptable maximal time to be alerted on cell phone of 1minute, with majority (n = 39) preferring a responder time 30 s (Fig. 1C) .
Importance of insurance coverage
Insurance coverage and cost were reported as determinant factors in the decision to use a seizure detector. Most respondents (67%) reported that the device would not be used unless covered by insurance and only a minority (6.6%) reported that they would use the device regardless of the cost or insurance coverage (Fig. 1D ).
Discussion
The objective of this study is to provide SDD developers with vetted insight on potential SDD users (patients and caregivers), including propensity of use and expectations around accessibility and design preferences.
This study confirms that there is significant concern regarding undetected seizures and a high level of interest in using a SDD.
Results suggest preference for continuous-use devices that can generate cell phone alerts in less than a minute after detection. Therefore, developers should envision smart designs that incorporate comfort and ease of use. Timely alerts to caregivers will prompt basic attention and administration of rescue medications.
Although not specifically addressed by our survey, these devices should allow for effective communicate through different platforms and devices. These integrations could provide access to other tools which improve patient care. For example, Hope et al. [11] emphasized the need for not only seizure detection but also seizure registration. This would improve documentation rates which are ordinarily mediocre due to seizure induced unawareness.
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Our survey shows that overall, potential users of wearable SDDs expect moderately high (>75%) sensitivity and specificity. Interestingly, respondents gave more relevance to sensitivity than specificity, showing that the preference is to avoid false negative alarms. Published reports of alarm generating wearable SDDs have shown a wide range of sensitivity. A device using combined accelerometry and electrodermal activity for detection of convulsive seizures reported sensitivity of 88-94% and an average false detection rate of 1 seizure in 24 h [12] . Other devices also based on accelerometry, which currently on the market, have reported specificity of 2-41% for detection of different seizure types, including convulsive seizures [5, 8] .
The design of highly sensitive and specific wearable seizure detection is challenging since different seizure types can cause changes in various biomarkers, and the value of a SDD is not only in the capability of identifying convulsive episodes but also in the identification of clinically subtle seizures. Therefore, a highly accurate device should consider this variability and incorporate various seizure detection mechanisms into a single device.
Accessibility was also a key factor. The majority indicated that a device would be used only if affordable or covered by insurance. Products for seizure detection currently available in the market range between US $200 and $600. For many, this is cost prohibitive. There is a need to validate the positive impact of seizure detection devices, not only for recognition of events that could lead to SUDEP, but also for seizure registration and monitoring. The latter would be useful during therapy changes and outcome documentation. Appropriate functionality validation is essential in paving the way for FDA approval, which will facilitate decisions regarding insurance coverage.
This study did not include the view of other stakeholders such as medical professionals and other formal caregivers. However, the aim was to identify the basic needs of potential users of a SDD. Therefore, although the information from this survey does not provide holistic customer validation, it presents relevant information for the development and implementation of SDDs since it clarifies the views of patients and caregivers, and aids in incorporating their perspectives into a more user-focused design.
Another limitation of the study is that it did not address the specific characteristics of the device. Other studies have addressed essential needs and desirable attributes of the ideal device including acceptable mode and site of sensors, availability of seizure prediction and the option of generating emergency calls as well as documentation of the seizures [11] . Nevertheless, no other study has addressed the questions that we asked to the potential users of such devices. Understanding the needs and expectations of the stakeholders is essential in the development of new technologies and this study helps fill that gap.
Conclusions
Wearable seizure detection devices are under development and the needs of potential customers should be considered in their design. PWE and their caregivers are interested in using these devices since there is significant worry and a real risk of SUDEP associated with undetected seizures. Data suggests a preference for these devices to be continuous-use, emphasizing the need for wearability or portability. These devices should generate an alarm in less than a minute after the seizure and be affordable or covered by insurance. False positive/false negative 0% n = 7 (7.6%)/n = 25 (27.2%) 25% n = 63 (68.5%)/n = 54 (58.7%) 50% n = 9 (9.8%)/n = 4 (4.3%) 75% n = 9 (9.8%)/n = 5 (5.4%) Other n = 4 (4.3%)/n = 4 (4.3%) Maximum time to be alerted <30 s n = 39 (42.4%) <1 min n = 31(33.7%) <3 min n = 13 (14.1%) <5 min n = 2 (2.2%) <15 min n = 1 (1.1%) <30 min n = 1 (1.1%) Other n = 4 (4.3%) Importance of insurance coverage Very important (would not use unless covered) n = 61 (67%)
Would possibly use if not covered (unless cost is prohibitive) n = 22 (24.2%)
Would definitely use (even if not covered) n = 6 (6.6%)
Other n = 2 (2.2%)
